Global AI Drug Target Discovery Service Market Research Report 2026(Status and Outlook)
AI Drug Target Discovery Service refers to a method that uses artificial intelligence technology to identify, validate and screen potential drug targets. By analyzing and mining massive biomedical data, this method uses machine learning, deep learning and other algorithms to predict and identify disease-related biomolecules, which can be used as targets for drug development, thereby accelerating the process of new drug discovery and research and development.Market Opportunities and Key Drivers:The AI Drug Target Discovery Service is experiencing unprecedented growth opportunities, with the core driving forces stemming from the triple resonance of technological innovation, policy support, and market demand. This growth is attributed to the disruptive impact of AI technology on the efficiency of drug development: traditional target discovery takes 5-7 years, while AI algorithms can shorten the cycle to 1-2 years, reducing the research cost by 40%-60%, and increasing the success rate of preclinical target validation from less than 10% to over 25%. At the policy level, China's "14th Five-Year Plan" has designated AI pharmaceuticals as a key development area, and the US FDA has also launched an "AI Priority" fast-track approval channel to accelerate the entry of AI-discovered targets into clinical trials. At the market demand end, the explosive growth in the treatment needs for chronic diseases and rare diseases has become the core driving force - for instance, AI successfully identified PD-L1's drug resistance mechanism-derived targets (such as LAG-3) in tumor target discovery, promoting the iteration of immunotherapy; in the rare disease field, AI analyzed the data from the 10,000 Genomes Project to identify new targets such as SMN2 enhancer for SMA (spinal muscular atrophy), filling the gaps in traditional research. Additionally, the capital enthusiasm continues to rise: in 2024, the global financing in the AI pharmaceutical field exceeded 12 billion US dollars, with target discovery enterprises accounting for 35% (such as Insilico Medicine, Exscientia, etc.), and pharmaceutical giants such as Eli Lilly and Roche have deeply invested in AI target platforms through cooperation or acquisition, further catalyzing industry expansion.Challenges and Future Directions:The AI Drug Target Discovery Service still faces multiple challenges in terms of data, technology, and ethics. The primary data bottleneck is the foremost issue: the fragmentation of biomedical data and privacy barriers lead to a lack of high-quality training data, for example, only 15% of protein interaction data related to target association meet the requirements of AI models, and the anonymization of patient genetic data weakens the accuracy of target prediction. The insufficient technical maturity also restricts application: deep learning models have poor explainability in predicting target mechanisms (the "black box problem"), resulting in 30% of AI predicted targets being unable to be verified through wet experiments; at the same time, the shortage of interdisciplinary talents separates algorithm development from biological validation, prolonging the transformation cycle. The regulatory and ethical risks are equally prominent: there are no unified standards for the intellectual property rights of AI-generated targets in various countries (such as whether AI can be listed as an inventor of a patent), and algorithm biases may ignore the characteristics of specific populations (such as the missing rate of genetic variation data for African Americans reaching 40%), exacerbating medical inequality. The future direction will focus on technology integration and ecosystem reconstruction: on the one hand, multimodal AI models (such as AlphaFold 3 combined with structure prediction and molecular dynamics simulation) can improve the accuracy of target screening, while quantum computing will solve the computational bottleneck of protein folding simulation; on the other hand, federated learning technology can integrate cross-border medical data under privacy protection, building a "global brain" for target discovery. At the industry level, the "AI + CRO" model (such as the collaboration between Wuxi Chemtech and Insilico) will promote the large-scale validation of targets, and blockchain technology may establish new standards for target data traceability and intellectual property rights confirmation. Ultimately, AI target discovery will evolve from a tool to a platform ecosystem, achieving a paradigm shift from "single-target breakthrough" to "disease network targeting" through open collaboration.
The global AI Drug Target Discovery Service market size was estimated at USD 3394.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 23.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global AI Drug Target Discovery Service market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global AI Drug Target Discovery Service market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the AI Drug Target Discovery Service market.
Global AI Drug Target Discovery Service Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Exscientia
Atomwise
Benevolent AI
Insitro
Xaira Therapeutics
Tempus AI
AbCellera
Recursion
Iktos
Genialis
Anima Biotech
BPGbio
Cradle
Isomorphic Labs
Generate Biomedicines
Latent Labs
Relay Therapeutics
Model Medicines
Nimbus Therapeutics
Schr?dinger
XtalPi
Insilico Medicine
Drug Farm
BioMap
Market Segmentation (by Type)
Target Identification Based on Omics Data and Biological Networks
Target Mining Based on Literature and Knowledge Graphs
Target Prediction Based on Structural Bioinformatics
Target Discovery Based on Phenotypic Screening and Virtual Patients
Market Segmentation (by Application)
Pharmaceutical Company
CRO and Universities
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the AI Drug Target Discovery Service Market
Overview of the regional outlook of the AI Drug Target Discovery Service Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the AI Drug Target Discovery Service Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of AI Drug Target Discovery Service, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global AI Drug Target Discovery Service market size was estimated at USD 3394.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 23.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global AI Drug Target Discovery Service market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global AI Drug Target Discovery Service market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the AI Drug Target Discovery Service market.
Global AI Drug Target Discovery Service Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Exscientia
Atomwise
Benevolent AI
Insitro
Xaira Therapeutics
Tempus AI
AbCellera
Recursion
Iktos
Genialis
Anima Biotech
BPGbio
Cradle
Isomorphic Labs
Generate Biomedicines
Latent Labs
Relay Therapeutics
Model Medicines
Nimbus Therapeutics
Schr?dinger
XtalPi
Insilico Medicine
Drug Farm
BioMap
Market Segmentation (by Type)
Target Identification Based on Omics Data and Biological Networks
Target Mining Based on Literature and Knowledge Graphs
Target Prediction Based on Structural Bioinformatics
Target Discovery Based on Phenotypic Screening and Virtual Patients
Market Segmentation (by Application)
Pharmaceutical Company
CRO and Universities
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the AI Drug Target Discovery Service Market
Overview of the regional outlook of the AI Drug Target Discovery Service Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the AI Drug Target Discovery Service Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of AI Drug Target Discovery Service, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of AI Drug Target Discovery Service
1.2 Key Market Segments
1.2.1 AI Drug Target Discovery Service Segment by Type
1.2.2 AI Drug Target Discovery Service Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AI DRUG TARGET DISCOVERY SERVICE MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AI DRUG TARGET DISCOVERY SERVICE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global AI Drug Target Discovery Service Product Life Cycle
3.3 Global AI Drug Target Discovery Service Revenue Market Share by Company (2020-2025)
3.4 AI Drug Target Discovery Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 AI Drug Target Discovery Service Market Competitive Situation and Trends
3.6.1 AI Drug Target Discovery Service Market Concentration Rate
3.6.2 Global 5 and 10 Largest AI Drug Target Discovery Service Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 AI DRUG TARGET DISCOVERY SERVICE VALUE CHAIN ANALYSIS
4.1 AI Drug Target Discovery Service Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AI DRUG TARGET DISCOVERY SERVICE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global AI Drug Target Discovery Service Market Porter's Five Forces Analysis
6 AI DRUG TARGET DISCOVERY SERVICE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global AI Drug Target Discovery Service Market by Type (2020-2025)
6.3 Global AI Drug Target Discovery Service Market Size Growth Rate by Type (2021-2025)
7 AI DRUG TARGET DISCOVERY SERVICE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global AI Drug Target Discovery Service Market Size (M USD) by Application (2020-2025)
7.3 Global AI Drug Target Discovery Service Market Size Growth Rate by Application (2021-2025)
8 AI DRUG TARGET DISCOVERY SERVICE MARKET SEGMENTATION BY REGION
8.1 Global AI Drug Target Discovery Service Market Size by Region
8.1.1 Global AI Drug Target Discovery Service Market Size by Region
8.1.2 Global AI Drug Target Discovery Service Market Size Market Share by Region
8.2 North America
8.2.1 North America AI Drug Target Discovery Service Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe AI Drug Target Discovery Service Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific AI Drug Target Discovery Service Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America AI Drug Target Discovery Service Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa AI Drug Target Discovery Service Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Exscientia
9.1.1 Exscientia Basic Information
9.1.2 Exscientia AI Drug Target Discovery Service Product Overview
9.1.3 Exscientia AI Drug Target Discovery Service Product Market Performance
9.1.4 Exscientia SWOT Analysis
9.1.5 Exscientia Business Overview
9.1.6 Exscientia Recent Developments
9.2 Atomwise
9.2.1 Atomwise Basic Information
9.2.2 Atomwise AI Drug Target Discovery Service Product Overview
9.2.3 Atomwise AI Drug Target Discovery Service Product Market Performance
9.2.4 Atomwise SWOT Analysis
9.2.5 Atomwise Business Overview
9.2.6 Atomwise Recent Developments
9.3 Benevolent AI
9.3.1 Benevolent AI Basic Information
9.3.2 Benevolent AI AI Drug Target Discovery Service Product Overview
9.3.3 Benevolent AI AI Drug Target Discovery Service Product Market Performance
9.3.4 Benevolent AI SWOT Analysis
9.3.5 Benevolent AI Business Overview
9.3.6 Benevolent AI Recent Developments
9.4 Insitro
9.4.1 Insitro Basic Information
9.4.2 Insitro AI Drug Target Discovery Service Product Overview
9.4.3 Insitro AI Drug Target Discovery Service Product Market Performance
9.4.4 Insitro Business Overview
9.4.5 Insitro Recent Developments
9.5 Xaira Therapeutics
9.5.1 Xaira Therapeutics Basic Information
9.5.2 Xaira Therapeutics AI Drug Target Discovery Service Product Overview
9.5.3 Xaira Therapeutics AI Drug Target Discovery Service Product Market Performance
9.5.4 Xaira Therapeutics Business Overview
9.5.5 Xaira Therapeutics Recent Developments
9.6 Tempus AI
9.6.1 Tempus AI Basic Information
9.6.2 Tempus AI AI Drug Target Discovery Service Product Overview
9.6.3 Tempus AI AI Drug Target Discovery Service Product Market Performance
9.6.4 Tempus AI Business Overview
9.6.5 Tempus AI Recent Developments
9.7 AbCellera
9.7.1 AbCellera Basic Information
9.7.2 AbCellera AI Drug Target Discovery Service Product Overview
9.7.3 AbCellera AI Drug Target Discovery Service Product Market Performance
9.7.4 AbCellera Business Overview
9.7.5 AbCellera Recent Developments
9.8 Recursion
9.8.1 Recursion Basic Information
9.8.2 Recursion AI Drug Target Discovery Service Product Overview
9.8.3 Recursion AI Drug Target Discovery Service Product Market Performance
9.8.4 Recursion Business Overview
9.8.5 Recursion Recent Developments
9.9 Iktos
9.9.1 Iktos Basic Information
9.9.2 Iktos AI Drug Target Discovery Service Product Overview
9.9.3 Iktos AI Drug Target Discovery Service Product Market Performance
9.9.4 Iktos Business Overview
9.9.5 Iktos Recent Developments
9.10 Genialis
9.10.1 Genialis Basic Information
9.10.2 Genialis AI Drug Target Discovery Service Product Overview
9.10.3 Genialis AI Drug Target Discovery Service Product Market Performance
9.10.4 Genialis Business Overview
9.10.5 Genialis Recent Developments
9.11 Anima Biotech
9.11.1 Anima Biotech Basic Information
9.11.2 Anima Biotech AI Drug Target Discovery Service Product Overview
9.11.3 Anima Biotech AI Drug Target Discovery Service Product Market Performance
9.11.4 Anima Biotech Business Overview
9.11.5 Anima Biotech Recent Developments
9.12 BPGbio
9.12.1 BPGbio Basic Information
9.12.2 BPGbio AI Drug Target Discovery Service Product Overview
9.12.3 BPGbio AI Drug Target Discovery Service Product Market Performance
9.12.4 BPGbio Business Overview
9.12.5 BPGbio Recent Developments
9.13 Cradle
9.13.1 Cradle Basic Information
9.13.2 Cradle AI Drug Target Discovery Service Product Overview
9.13.3 Cradle AI Drug Target Discovery Service Product Market Performance
9.13.4 Cradle Business Overview
9.13.5 Cradle Recent Developments
9.14 Isomorphic Labs
9.14.1 Isomorphic Labs Basic Information
9.14.2 Isomorphic Labs AI Drug Target Discovery Service Product Overview
9.14.3 Isomorphic Labs AI Drug Target Discovery Service Product Market Performance
9.14.4 Isomorphic Labs Business Overview
9.14.5 Isomorphic Labs Recent Developments
9.15 Generate Biomedicines
9.15.1 Generate Biomedicines Basic Information
9.15.2 Generate Biomedicines AI Drug Target Discovery Service Product Overview
9.15.3 Generate Biomedicines AI Drug Target Discovery Service Product Market Performance
9.15.4 Generate Biomedicines Business Overview
9.15.5 Generate Biomedicines Recent Developments
9.16 Latent Labs
9.16.1 Latent Labs Basic Information
9.16.2 Latent Labs AI Drug Target Discovery Service Product Overview
9.16.3 Latent Labs AI Drug Target Discovery Service Product Market Performance
9.16.4 Latent Labs Business Overview
9.16.5 Latent Labs Recent Developments
9.17 Relay Therapeutics
9.17.1 Relay Therapeutics Basic Information
9.17.2 Relay Therapeutics AI Drug Target Discovery Service Product Overview
9.17.3 Relay Therapeutics AI Drug Target Discovery Service Product Market Performance
9.17.4 Relay Therapeutics Business Overview
9.17.5 Relay Therapeutics Recent Developments
9.18 Model Medicines
9.18.1 Model Medicines Basic Information
9.18.2 Model Medicines AI Drug Target Discovery Service Product Overview
9.18.3 Model Medicines AI Drug Target Discovery Service Product Market Performance
9.18.4 Model Medicines Business Overview
9.18.5 Model Medicines Recent Developments
9.19 Nimbus Therapeutics
9.19.1 Nimbus Therapeutics Basic Information
9.19.2 Nimbus Therapeutics AI Drug Target Discovery Service Product Overview
9.19.3 Nimbus Therapeutics AI Drug Target Discovery Service Product Market Performance
9.19.4 Nimbus Therapeutics Business Overview
9.19.5 Nimbus Therapeutics Recent Developments
9.20 Schr?dinger
9.20.1 Schr?dinger Basic Information
9.20.2 Schr?dinger AI Drug Target Discovery Service Product Overview
9.20.3 Schr?dinger AI Drug Target Discovery Service Product Market Performance
9.20.4 Schr?dinger Business Overview
9.20.5 Schr?dinger Recent Developments
9.21 XtalPi
9.21.1 XtalPi Basic Information
9.21.2 XtalPi AI Drug Target Discovery Service Product Overview
9.21.3 XtalPi AI Drug Target Discovery Service Product Market Performance
9.21.4 XtalPi Business Overview
9.21.5 XtalPi Recent Developments
9.22 Insilico Medicine
9.22.1 Insilico Medicine Basic Information
9.22.2 Insilico Medicine AI Drug Target Discovery Service Product Overview
9.22.3 Insilico Medicine AI Drug Target Discovery Service Product Market Performance
9.22.4 Insilico Medicine Business Overview
9.22.5 Insilico Medicine Recent Developments
9.23 Drug Farm
9.23.1 Drug Farm Basic Information
9.23.2 Drug Farm AI Drug Target Discovery Service Product Overview
9.23.3 Drug Farm AI Drug Target Discovery Service Product Market Performance
9.23.4 Drug Farm Business Overview
9.23.5 Drug Farm Recent Developments
9.24 BioMap
9.24.1 BioMap Basic Information
9.24.2 BioMap AI Drug Target Discovery Service Product Overview
9.24.3 BioMap AI Drug Target Discovery Service Product Market Performance
9.24.4 BioMap Business Overview
9.24.5 BioMap Recent Developments
10 AI DRUG TARGET DISCOVERY SERVICE MARKET FORECAST BY REGION
10.1 Global AI Drug Target Discovery Service Market Size Forecast
10.2 Global AI Drug Target Discovery Service Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe AI Drug Target Discovery Service Market Size Forecast by Country
10.2.3 Asia Pacific AI Drug Target Discovery Service Market Size Forecast by Region
10.2.4 South America AI Drug Target Discovery Service Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of AI Drug Target Discovery Service by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global AI Drug Target Discovery Service Market Forecast by Type (2026-2035)
11.1.1 Global AI Drug Target Discovery Service Market Size Forecast by Type (2026-2035)
11.2 Global AI Drug Target Discovery Service Market Forecast by Application (2026-2035)
11.2.1 Global AI Drug Target Discovery Service Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of AI Drug Target Discovery Service
1.2 Key Market Segments
1.2.1 AI Drug Target Discovery Service Segment by Type
1.2.2 AI Drug Target Discovery Service Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AI DRUG TARGET DISCOVERY SERVICE MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AI DRUG TARGET DISCOVERY SERVICE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global AI Drug Target Discovery Service Product Life Cycle
3.3 Global AI Drug Target Discovery Service Revenue Market Share by Company (2020-2025)
3.4 AI Drug Target Discovery Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 AI Drug Target Discovery Service Market Competitive Situation and Trends
3.6.1 AI Drug Target Discovery Service Market Concentration Rate
3.6.2 Global 5 and 10 Largest AI Drug Target Discovery Service Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 AI DRUG TARGET DISCOVERY SERVICE VALUE CHAIN ANALYSIS
4.1 AI Drug Target Discovery Service Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AI DRUG TARGET DISCOVERY SERVICE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global AI Drug Target Discovery Service Market Porter's Five Forces Analysis
6 AI DRUG TARGET DISCOVERY SERVICE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global AI Drug Target Discovery Service Market by Type (2020-2025)
6.3 Global AI Drug Target Discovery Service Market Size Growth Rate by Type (2021-2025)
7 AI DRUG TARGET DISCOVERY SERVICE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global AI Drug Target Discovery Service Market Size (M USD) by Application (2020-2025)
7.3 Global AI Drug Target Discovery Service Market Size Growth Rate by Application (2021-2025)
8 AI DRUG TARGET DISCOVERY SERVICE MARKET SEGMENTATION BY REGION
8.1 Global AI Drug Target Discovery Service Market Size by Region
8.1.1 Global AI Drug Target Discovery Service Market Size by Region
8.1.2 Global AI Drug Target Discovery Service Market Size Market Share by Region
8.2 North America
8.2.1 North America AI Drug Target Discovery Service Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe AI Drug Target Discovery Service Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific AI Drug Target Discovery Service Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America AI Drug Target Discovery Service Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa AI Drug Target Discovery Service Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Exscientia
9.1.1 Exscientia Basic Information
9.1.2 Exscientia AI Drug Target Discovery Service Product Overview
9.1.3 Exscientia AI Drug Target Discovery Service Product Market Performance
9.1.4 Exscientia SWOT Analysis
9.1.5 Exscientia Business Overview
9.1.6 Exscientia Recent Developments
9.2 Atomwise
9.2.1 Atomwise Basic Information
9.2.2 Atomwise AI Drug Target Discovery Service Product Overview
9.2.3 Atomwise AI Drug Target Discovery Service Product Market Performance
9.2.4 Atomwise SWOT Analysis
9.2.5 Atomwise Business Overview
9.2.6 Atomwise Recent Developments
9.3 Benevolent AI
9.3.1 Benevolent AI Basic Information
9.3.2 Benevolent AI AI Drug Target Discovery Service Product Overview
9.3.3 Benevolent AI AI Drug Target Discovery Service Product Market Performance
9.3.4 Benevolent AI SWOT Analysis
9.3.5 Benevolent AI Business Overview
9.3.6 Benevolent AI Recent Developments
9.4 Insitro
9.4.1 Insitro Basic Information
9.4.2 Insitro AI Drug Target Discovery Service Product Overview
9.4.3 Insitro AI Drug Target Discovery Service Product Market Performance
9.4.4 Insitro Business Overview
9.4.5 Insitro Recent Developments
9.5 Xaira Therapeutics
9.5.1 Xaira Therapeutics Basic Information
9.5.2 Xaira Therapeutics AI Drug Target Discovery Service Product Overview
9.5.3 Xaira Therapeutics AI Drug Target Discovery Service Product Market Performance
9.5.4 Xaira Therapeutics Business Overview
9.5.5 Xaira Therapeutics Recent Developments
9.6 Tempus AI
9.6.1 Tempus AI Basic Information
9.6.2 Tempus AI AI Drug Target Discovery Service Product Overview
9.6.3 Tempus AI AI Drug Target Discovery Service Product Market Performance
9.6.4 Tempus AI Business Overview
9.6.5 Tempus AI Recent Developments
9.7 AbCellera
9.7.1 AbCellera Basic Information
9.7.2 AbCellera AI Drug Target Discovery Service Product Overview
9.7.3 AbCellera AI Drug Target Discovery Service Product Market Performance
9.7.4 AbCellera Business Overview
9.7.5 AbCellera Recent Developments
9.8 Recursion
9.8.1 Recursion Basic Information
9.8.2 Recursion AI Drug Target Discovery Service Product Overview
9.8.3 Recursion AI Drug Target Discovery Service Product Market Performance
9.8.4 Recursion Business Overview
9.8.5 Recursion Recent Developments
9.9 Iktos
9.9.1 Iktos Basic Information
9.9.2 Iktos AI Drug Target Discovery Service Product Overview
9.9.3 Iktos AI Drug Target Discovery Service Product Market Performance
9.9.4 Iktos Business Overview
9.9.5 Iktos Recent Developments
9.10 Genialis
9.10.1 Genialis Basic Information
9.10.2 Genialis AI Drug Target Discovery Service Product Overview
9.10.3 Genialis AI Drug Target Discovery Service Product Market Performance
9.10.4 Genialis Business Overview
9.10.5 Genialis Recent Developments
9.11 Anima Biotech
9.11.1 Anima Biotech Basic Information
9.11.2 Anima Biotech AI Drug Target Discovery Service Product Overview
9.11.3 Anima Biotech AI Drug Target Discovery Service Product Market Performance
9.11.4 Anima Biotech Business Overview
9.11.5 Anima Biotech Recent Developments
9.12 BPGbio
9.12.1 BPGbio Basic Information
9.12.2 BPGbio AI Drug Target Discovery Service Product Overview
9.12.3 BPGbio AI Drug Target Discovery Service Product Market Performance
9.12.4 BPGbio Business Overview
9.12.5 BPGbio Recent Developments
9.13 Cradle
9.13.1 Cradle Basic Information
9.13.2 Cradle AI Drug Target Discovery Service Product Overview
9.13.3 Cradle AI Drug Target Discovery Service Product Market Performance
9.13.4 Cradle Business Overview
9.13.5 Cradle Recent Developments
9.14 Isomorphic Labs
9.14.1 Isomorphic Labs Basic Information
9.14.2 Isomorphic Labs AI Drug Target Discovery Service Product Overview
9.14.3 Isomorphic Labs AI Drug Target Discovery Service Product Market Performance
9.14.4 Isomorphic Labs Business Overview
9.14.5 Isomorphic Labs Recent Developments
9.15 Generate Biomedicines
9.15.1 Generate Biomedicines Basic Information
9.15.2 Generate Biomedicines AI Drug Target Discovery Service Product Overview
9.15.3 Generate Biomedicines AI Drug Target Discovery Service Product Market Performance
9.15.4 Generate Biomedicines Business Overview
9.15.5 Generate Biomedicines Recent Developments
9.16 Latent Labs
9.16.1 Latent Labs Basic Information
9.16.2 Latent Labs AI Drug Target Discovery Service Product Overview
9.16.3 Latent Labs AI Drug Target Discovery Service Product Market Performance
9.16.4 Latent Labs Business Overview
9.16.5 Latent Labs Recent Developments
9.17 Relay Therapeutics
9.17.1 Relay Therapeutics Basic Information
9.17.2 Relay Therapeutics AI Drug Target Discovery Service Product Overview
9.17.3 Relay Therapeutics AI Drug Target Discovery Service Product Market Performance
9.17.4 Relay Therapeutics Business Overview
9.17.5 Relay Therapeutics Recent Developments
9.18 Model Medicines
9.18.1 Model Medicines Basic Information
9.18.2 Model Medicines AI Drug Target Discovery Service Product Overview
9.18.3 Model Medicines AI Drug Target Discovery Service Product Market Performance
9.18.4 Model Medicines Business Overview
9.18.5 Model Medicines Recent Developments
9.19 Nimbus Therapeutics
9.19.1 Nimbus Therapeutics Basic Information
9.19.2 Nimbus Therapeutics AI Drug Target Discovery Service Product Overview
9.19.3 Nimbus Therapeutics AI Drug Target Discovery Service Product Market Performance
9.19.4 Nimbus Therapeutics Business Overview
9.19.5 Nimbus Therapeutics Recent Developments
9.20 Schr?dinger
9.20.1 Schr?dinger Basic Information
9.20.2 Schr?dinger AI Drug Target Discovery Service Product Overview
9.20.3 Schr?dinger AI Drug Target Discovery Service Product Market Performance
9.20.4 Schr?dinger Business Overview
9.20.5 Schr?dinger Recent Developments
9.21 XtalPi
9.21.1 XtalPi Basic Information
9.21.2 XtalPi AI Drug Target Discovery Service Product Overview
9.21.3 XtalPi AI Drug Target Discovery Service Product Market Performance
9.21.4 XtalPi Business Overview
9.21.5 XtalPi Recent Developments
9.22 Insilico Medicine
9.22.1 Insilico Medicine Basic Information
9.22.2 Insilico Medicine AI Drug Target Discovery Service Product Overview
9.22.3 Insilico Medicine AI Drug Target Discovery Service Product Market Performance
9.22.4 Insilico Medicine Business Overview
9.22.5 Insilico Medicine Recent Developments
9.23 Drug Farm
9.23.1 Drug Farm Basic Information
9.23.2 Drug Farm AI Drug Target Discovery Service Product Overview
9.23.3 Drug Farm AI Drug Target Discovery Service Product Market Performance
9.23.4 Drug Farm Business Overview
9.23.5 Drug Farm Recent Developments
9.24 BioMap
9.24.1 BioMap Basic Information
9.24.2 BioMap AI Drug Target Discovery Service Product Overview
9.24.3 BioMap AI Drug Target Discovery Service Product Market Performance
9.24.4 BioMap Business Overview
9.24.5 BioMap Recent Developments
10 AI DRUG TARGET DISCOVERY SERVICE MARKET FORECAST BY REGION
10.1 Global AI Drug Target Discovery Service Market Size Forecast
10.2 Global AI Drug Target Discovery Service Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe AI Drug Target Discovery Service Market Size Forecast by Country
10.2.3 Asia Pacific AI Drug Target Discovery Service Market Size Forecast by Region
10.2.4 South America AI Drug Target Discovery Service Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of AI Drug Target Discovery Service by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global AI Drug Target Discovery Service Market Forecast by Type (2026-2035)
11.1.1 Global AI Drug Target Discovery Service Market Size Forecast by Type (2026-2035)
11.2 Global AI Drug Target Discovery Service Market Forecast by Application (2026-2035)
11.2.1 Global AI Drug Target Discovery Service Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global AI Drug Target Discovery Service Market Size by Type (M USD)
Table 4. Global AI Drug Target Discovery Service Market Size by Application
Table 5. AI Drug Target Discovery Service Market Size Comparison by Region (M USD)
Table 6. Global AI Drug Target Discovery Service Revenue (M USD) by Company (2020-2025)
Table 7. Global AI Drug Target Discovery Service Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Target Discovery Service as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global AI Drug Target Discovery Service Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. AI Drug Target Discovery Service Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global AI Drug Target Discovery Service Market Size by Type (M USD)
Table 22. Global AI Drug Target Discovery Service Market Size (M USD) by Type (2020-2025)
Table 23. Global AI Drug Target Discovery Service Market Share by Type (2020-2025)
Table 24. Global AI Drug Target Discovery Service Market Size Growth Rate by Type (2021-2025)
Table 25. Global AI Drug Target Discovery Service Market Size by Application
Table 26. Global AI Drug Target Discovery Service Market Size by Application (2020-2025) & (M USD)
Table 27. Global AI Drug Target Discovery Service Market Share by Application (2020-2025)
Table 28. Global AI Drug Target Discovery Service Market Size Growth Rate by Application (2021-2025)
Table 29. Global AI Drug Target Discovery Service Market Size by Region (2020-2025) & (M USD)
Table 30. Global AI Drug Target Discovery Service Market Size Market Share by Region (2020-2025)
Table 31. North America AI Drug Target Discovery Service Market Size by Country (2020-2025) & (M USD)
Table 32. Europe AI Drug Target Discovery Service Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific AI Drug Target Discovery Service Market Size by Region (2020-2025) & (M USD)
Table 34. South America AI Drug Target Discovery Service Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa AI Drug Target Discovery Service Market Size by Region (2020-2025) & (M USD)
Table 36. Exscientia Basic Information
Table 37. Exscientia AI Drug Target Discovery Service Product Overview
Table 38. Exscientia AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Exscientia SWOT Analysis
Table 40. Exscientia Business Overview
Table 41. Exscientia Recent Developments
Table 42. Atomwise Basic Information
Table 43. Atomwise AI Drug Target Discovery Service Product Overview
Table 44. Atomwise AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Atomwise SWOT Analysis
Table 46. Atomwise Business Overview
Table 47. Atomwise Recent Developments
Table 48. Benevolent AI Basic Information
Table 49. Benevolent AI AI Drug Target Discovery Service Product Overview
Table 50. Benevolent AI AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Benevolent AI SWOT Analysis
Table 52. Benevolent AI Business Overview
Table 53. Benevolent AI Recent Developments
Table 54. Insitro Basic Information
Table 55. Insitro AI Drug Target Discovery Service Product Overview
Table 56. Insitro AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Insitro Business Overview
Table 58. Insitro Recent Developments
Table 59. Xaira Therapeutics Basic Information
Table 60. Xaira Therapeutics AI Drug Target Discovery Service Product Overview
Table 61. Xaira Therapeutics AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Xaira Therapeutics Business Overview
Table 63. Xaira Therapeutics Recent Developments
Table 64. Tempus AI Basic Information
Table 65. Tempus AI AI Drug Target Discovery Service Product Overview
Table 66. Tempus AI AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Tempus AI Business Overview
Table 68. Tempus AI Recent Developments
Table 69. AbCellera Basic Information
Table 70. AbCellera AI Drug Target Discovery Service Product Overview
Table 71. AbCellera AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 72. AbCellera Business Overview
Table 73. AbCellera Recent Developments
Table 74. Recursion Basic Information
Table 75. Recursion AI Drug Target Discovery Service Product Overview
Table 76. Recursion AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Recursion Business Overview
Table 78. Recursion Recent Developments
Table 79. Iktos Basic Information
Table 80. Iktos AI Drug Target Discovery Service Product Overview
Table 81. Iktos AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Iktos Business Overview
Table 83. Iktos Recent Developments
Table 84. Genialis Basic Information
Table 85. Genialis AI Drug Target Discovery Service Product Overview
Table 86. Genialis AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Genialis Business Overview
Table 88. Genialis Recent Developments
Table 89. Anima Biotech Basic Information
Table 90. Anima Biotech AI Drug Target Discovery Service Product Overview
Table 91. Anima Biotech AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Anima Biotech Business Overview
Table 93. Anima Biotech Recent Developments
Table 94. BPGbio Basic Information
Table 95. BPGbio AI Drug Target Discovery Service Product Overview
Table 96. BPGbio AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 97. BPGbio Business Overview
Table 98. BPGbio Recent Developments
Table 99. Cradle Basic Information
Table 100. Cradle AI Drug Target Discovery Service Product Overview
Table 101. Cradle AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Cradle Business Overview
Table 103. Cradle Recent Developments
Table 104. Isomorphic Labs Basic Information
Table 105. Isomorphic Labs AI Drug Target Discovery Service Product Overview
Table 106. Isomorphic Labs AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Isomorphic Labs Business Overview
Table 108. Isomorphic Labs Recent Developments
Table 109. Generate Biomedicines Basic Information
Table 110. Generate Biomedicines AI Drug Target Discovery Service Product Overview
Table 111. Generate Biomedicines AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Generate Biomedicines Business Overview
Table 113. Generate Biomedicines Recent Developments
Table 114. Latent Labs Basic Information
Table 115. Latent Labs AI Drug Target Discovery Service Product Overview
Table 116. Latent Labs AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Latent Labs Business Overview
Table 118. Latent Labs Recent Developments
Table 119. Relay Therapeutics Basic Information
Table 120. Relay Therapeutics AI Drug Target Discovery Service Product Overview
Table 121. Relay Therapeutics AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 122. Relay Therapeutics Business Overview
Table 123. Relay Therapeutics Recent Developments
Table 124. Model Medicines Basic Information
Table 125. Model Medicines AI Drug Target Discovery Service Product Overview
Table 126. Model Medicines AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 127. Model Medicines Business Overview
Table 128. Model Medicines Recent Developments
Table 129. Nimbus Therapeutics Basic Information
Table 130. Nimbus Therapeutics AI Drug Target Discovery Service Product Overview
Table 131. Nimbus Therapeutics AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 132. Nimbus Therapeutics Business Overview
Table 133. Nimbus Therapeutics Recent Developments
Table 134. Schr?dinger Basic Information
Table 135. Schr?dinger AI Drug Target Discovery Service Product Overview
Table 136. Schr?dinger AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 137. Schr?dinger Business Overview
Table 138. Schr?dinger Recent Developments
Table 139. XtalPi Basic Information
Table 140. XtalPi AI Drug Target Discovery Service Product Overview
Table 141. XtalPi AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 142. XtalPi Business Overview
Table 143. XtalPi Recent Developments
Table 144. Insilico Medicine Basic Information
Table 145. Insilico Medicine AI Drug Target Discovery Service Product Overview
Table 146. Insilico Medicine AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 147. Insilico Medicine Business Overview
Table 148. Insilico Medicine Recent Developments
Table 149. Drug Farm Basic Information
Table 150. Drug Farm AI Drug Target Discovery Service Product Overview
Table 151. Drug Farm AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 152. Drug Farm Business Overview
Table 153. Drug Farm Recent Developments
Table 154. BioMap Basic Information
Table 155. BioMap AI Drug Target Discovery Service Product Overview
Table 156. BioMap AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 157. BioMap Business Overview
Table 158. BioMap Recent Developments
Table 159. Global AI Drug Target Discovery Service Market Size Forecast by Region (2026-2035) & (M USD)
Table 160. North America AI Drug Target Discovery Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Europe AI Drug Target Discovery Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 162. Asia Pacific AI Drug Target Discovery Service Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America AI Drug Target Discovery Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Middle East and Africa AI Drug Target Discovery Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Global AI Drug Target Discovery Service Market Size Forecast by Type (2026-2035) & (M USD)
Table 166. Global AI Drug Target Discovery Service Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global AI Drug Target Discovery Service Market Size by Type (M USD)
Table 4. Global AI Drug Target Discovery Service Market Size by Application
Table 5. AI Drug Target Discovery Service Market Size Comparison by Region (M USD)
Table 6. Global AI Drug Target Discovery Service Revenue (M USD) by Company (2020-2025)
Table 7. Global AI Drug Target Discovery Service Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Target Discovery Service as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global AI Drug Target Discovery Service Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. AI Drug Target Discovery Service Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global AI Drug Target Discovery Service Market Size by Type (M USD)
Table 22. Global AI Drug Target Discovery Service Market Size (M USD) by Type (2020-2025)
Table 23. Global AI Drug Target Discovery Service Market Share by Type (2020-2025)
Table 24. Global AI Drug Target Discovery Service Market Size Growth Rate by Type (2021-2025)
Table 25. Global AI Drug Target Discovery Service Market Size by Application
Table 26. Global AI Drug Target Discovery Service Market Size by Application (2020-2025) & (M USD)
Table 27. Global AI Drug Target Discovery Service Market Share by Application (2020-2025)
Table 28. Global AI Drug Target Discovery Service Market Size Growth Rate by Application (2021-2025)
Table 29. Global AI Drug Target Discovery Service Market Size by Region (2020-2025) & (M USD)
Table 30. Global AI Drug Target Discovery Service Market Size Market Share by Region (2020-2025)
Table 31. North America AI Drug Target Discovery Service Market Size by Country (2020-2025) & (M USD)
Table 32. Europe AI Drug Target Discovery Service Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific AI Drug Target Discovery Service Market Size by Region (2020-2025) & (M USD)
Table 34. South America AI Drug Target Discovery Service Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa AI Drug Target Discovery Service Market Size by Region (2020-2025) & (M USD)
Table 36. Exscientia Basic Information
Table 37. Exscientia AI Drug Target Discovery Service Product Overview
Table 38. Exscientia AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Exscientia SWOT Analysis
Table 40. Exscientia Business Overview
Table 41. Exscientia Recent Developments
Table 42. Atomwise Basic Information
Table 43. Atomwise AI Drug Target Discovery Service Product Overview
Table 44. Atomwise AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Atomwise SWOT Analysis
Table 46. Atomwise Business Overview
Table 47. Atomwise Recent Developments
Table 48. Benevolent AI Basic Information
Table 49. Benevolent AI AI Drug Target Discovery Service Product Overview
Table 50. Benevolent AI AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Benevolent AI SWOT Analysis
Table 52. Benevolent AI Business Overview
Table 53. Benevolent AI Recent Developments
Table 54. Insitro Basic Information
Table 55. Insitro AI Drug Target Discovery Service Product Overview
Table 56. Insitro AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Insitro Business Overview
Table 58. Insitro Recent Developments
Table 59. Xaira Therapeutics Basic Information
Table 60. Xaira Therapeutics AI Drug Target Discovery Service Product Overview
Table 61. Xaira Therapeutics AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Xaira Therapeutics Business Overview
Table 63. Xaira Therapeutics Recent Developments
Table 64. Tempus AI Basic Information
Table 65. Tempus AI AI Drug Target Discovery Service Product Overview
Table 66. Tempus AI AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Tempus AI Business Overview
Table 68. Tempus AI Recent Developments
Table 69. AbCellera Basic Information
Table 70. AbCellera AI Drug Target Discovery Service Product Overview
Table 71. AbCellera AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 72. AbCellera Business Overview
Table 73. AbCellera Recent Developments
Table 74. Recursion Basic Information
Table 75. Recursion AI Drug Target Discovery Service Product Overview
Table 76. Recursion AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Recursion Business Overview
Table 78. Recursion Recent Developments
Table 79. Iktos Basic Information
Table 80. Iktos AI Drug Target Discovery Service Product Overview
Table 81. Iktos AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Iktos Business Overview
Table 83. Iktos Recent Developments
Table 84. Genialis Basic Information
Table 85. Genialis AI Drug Target Discovery Service Product Overview
Table 86. Genialis AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Genialis Business Overview
Table 88. Genialis Recent Developments
Table 89. Anima Biotech Basic Information
Table 90. Anima Biotech AI Drug Target Discovery Service Product Overview
Table 91. Anima Biotech AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Anima Biotech Business Overview
Table 93. Anima Biotech Recent Developments
Table 94. BPGbio Basic Information
Table 95. BPGbio AI Drug Target Discovery Service Product Overview
Table 96. BPGbio AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 97. BPGbio Business Overview
Table 98. BPGbio Recent Developments
Table 99. Cradle Basic Information
Table 100. Cradle AI Drug Target Discovery Service Product Overview
Table 101. Cradle AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Cradle Business Overview
Table 103. Cradle Recent Developments
Table 104. Isomorphic Labs Basic Information
Table 105. Isomorphic Labs AI Drug Target Discovery Service Product Overview
Table 106. Isomorphic Labs AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Isomorphic Labs Business Overview
Table 108. Isomorphic Labs Recent Developments
Table 109. Generate Biomedicines Basic Information
Table 110. Generate Biomedicines AI Drug Target Discovery Service Product Overview
Table 111. Generate Biomedicines AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Generate Biomedicines Business Overview
Table 113. Generate Biomedicines Recent Developments
Table 114. Latent Labs Basic Information
Table 115. Latent Labs AI Drug Target Discovery Service Product Overview
Table 116. Latent Labs AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Latent Labs Business Overview
Table 118. Latent Labs Recent Developments
Table 119. Relay Therapeutics Basic Information
Table 120. Relay Therapeutics AI Drug Target Discovery Service Product Overview
Table 121. Relay Therapeutics AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 122. Relay Therapeutics Business Overview
Table 123. Relay Therapeutics Recent Developments
Table 124. Model Medicines Basic Information
Table 125. Model Medicines AI Drug Target Discovery Service Product Overview
Table 126. Model Medicines AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 127. Model Medicines Business Overview
Table 128. Model Medicines Recent Developments
Table 129. Nimbus Therapeutics Basic Information
Table 130. Nimbus Therapeutics AI Drug Target Discovery Service Product Overview
Table 131. Nimbus Therapeutics AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 132. Nimbus Therapeutics Business Overview
Table 133. Nimbus Therapeutics Recent Developments
Table 134. Schr?dinger Basic Information
Table 135. Schr?dinger AI Drug Target Discovery Service Product Overview
Table 136. Schr?dinger AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 137. Schr?dinger Business Overview
Table 138. Schr?dinger Recent Developments
Table 139. XtalPi Basic Information
Table 140. XtalPi AI Drug Target Discovery Service Product Overview
Table 141. XtalPi AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 142. XtalPi Business Overview
Table 143. XtalPi Recent Developments
Table 144. Insilico Medicine Basic Information
Table 145. Insilico Medicine AI Drug Target Discovery Service Product Overview
Table 146. Insilico Medicine AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 147. Insilico Medicine Business Overview
Table 148. Insilico Medicine Recent Developments
Table 149. Drug Farm Basic Information
Table 150. Drug Farm AI Drug Target Discovery Service Product Overview
Table 151. Drug Farm AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 152. Drug Farm Business Overview
Table 153. Drug Farm Recent Developments
Table 154. BioMap Basic Information
Table 155. BioMap AI Drug Target Discovery Service Product Overview
Table 156. BioMap AI Drug Target Discovery Service Revenue (M USD) and Gross Margin (2020-2025)
Table 157. BioMap Business Overview
Table 158. BioMap Recent Developments
Table 159. Global AI Drug Target Discovery Service Market Size Forecast by Region (2026-2035) & (M USD)
Table 160. North America AI Drug Target Discovery Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Europe AI Drug Target Discovery Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 162. Asia Pacific AI Drug Target Discovery Service Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America AI Drug Target Discovery Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Middle East and Africa AI Drug Target Discovery Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Global AI Drug Target Discovery Service Market Size Forecast by Type (2026-2035) & (M USD)
Table 166. Global AI Drug Target Discovery Service Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of AI Drug Target Discovery Service
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global AI Drug Target Discovery Service Market Size (M USD), 2025-2035
Figure 5. Global AI Drug Target Discovery Service Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. AI Drug Target Discovery Service Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global AI Drug Target Discovery Service Product Life Cycle
Figure 12. Global AI Drug Target Discovery Service Revenue Share by Company in 2025
Figure 13. AI Drug Target Discovery Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by AI Drug Target Discovery Service Revenue in 2025
Figure 15. Value Chain Map of AI Drug Target Discovery Service
Figure 16. Global AI Drug Target Discovery Service Market PEST Analysis
Figure 17. Global AI Drug Target Discovery Service Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global AI Drug Target Discovery Service Market Share by Type
Figure 20. Market Share of AI Drug Target Discovery Service by Type (2020-2025)
Figure 21. Global AI Drug Target Discovery Service Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global AI Drug Target Discovery Service Market Share by Application
Figure 24. Global AI Drug Target Discovery Service Market Share by Application (2020-2025)
Figure 25. Global AI Drug Target Discovery Service Market Share by Application in 2024
Figure 26. Global AI Drug Target Discovery Service Market Size Growth Rate by Application (2021-2025)
Figure 27. Global AI Drug Target Discovery Service Market Size Market Share by Region (2020-2025)
Figure 28. North America AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America AI Drug Target Discovery Service Market Size Market Share by Country in 2024
Figure 30. U.S. AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada AI Drug Target Discovery Service Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico AI Drug Target Discovery Service Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe AI Drug Target Discovery Service Market Share by Country in 2024
Figure 35. Germany AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific AI Drug Target Discovery Service Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific AI Drug Target Discovery Service Market Size Market Share by Region in 2024
Figure 42. China AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America AI Drug Target Discovery Service Market Size and Growth Rate (M USD)
Figure 48. South America AI Drug Target Discovery Service Market Size Market Share by Country in 2024
Figure 49. Brazil AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa AI Drug Target Discovery Service Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa AI Drug Target Discovery Service Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global AI Drug Target Discovery Service Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global AI Drug Target Discovery Service Market Share Forecast by Type (2026-2035)
Figure 61. Global AI Drug Target Discovery Service Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of AI Drug Target Discovery Service
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global AI Drug Target Discovery Service Market Size (M USD), 2025-2035
Figure 5. Global AI Drug Target Discovery Service Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. AI Drug Target Discovery Service Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global AI Drug Target Discovery Service Product Life Cycle
Figure 12. Global AI Drug Target Discovery Service Revenue Share by Company in 2025
Figure 13. AI Drug Target Discovery Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by AI Drug Target Discovery Service Revenue in 2025
Figure 15. Value Chain Map of AI Drug Target Discovery Service
Figure 16. Global AI Drug Target Discovery Service Market PEST Analysis
Figure 17. Global AI Drug Target Discovery Service Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global AI Drug Target Discovery Service Market Share by Type
Figure 20. Market Share of AI Drug Target Discovery Service by Type (2020-2025)
Figure 21. Global AI Drug Target Discovery Service Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global AI Drug Target Discovery Service Market Share by Application
Figure 24. Global AI Drug Target Discovery Service Market Share by Application (2020-2025)
Figure 25. Global AI Drug Target Discovery Service Market Share by Application in 2024
Figure 26. Global AI Drug Target Discovery Service Market Size Growth Rate by Application (2021-2025)
Figure 27. Global AI Drug Target Discovery Service Market Size Market Share by Region (2020-2025)
Figure 28. North America AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America AI Drug Target Discovery Service Market Size Market Share by Country in 2024
Figure 30. U.S. AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada AI Drug Target Discovery Service Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico AI Drug Target Discovery Service Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe AI Drug Target Discovery Service Market Share by Country in 2024
Figure 35. Germany AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific AI Drug Target Discovery Service Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific AI Drug Target Discovery Service Market Size Market Share by Region in 2024
Figure 42. China AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America AI Drug Target Discovery Service Market Size and Growth Rate (M USD)
Figure 48. South America AI Drug Target Discovery Service Market Size Market Share by Country in 2024
Figure 49. Brazil AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa AI Drug Target Discovery Service Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa AI Drug Target Discovery Service Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa AI Drug Target Discovery Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global AI Drug Target Discovery Service Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global AI Drug Target Discovery Service Market Share Forecast by Type (2026-2035)
Figure 61. Global AI Drug Target Discovery Service Market Share Forecast by Application (2026-2035)
